The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

J Clin Med · 2023 · PMC10056693 · PMID 36983384

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

Both CCL5 rs2280788-GC and CCL5 rs2280789-CC genotypes in their study showed a slightly significant association with TNBC risk [ 30 ].

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.